HBSP (USA)
-
Cipla (Spanish version)
Deshpande, Rohit; Winig, LauraCase HBS-520S15MarketingThe head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line could become unsaleable (given that it is based on product patents protected in industrialized countries). Describes Cipla's role in forcing global pharmaceutical companies to lower th...Starting at €8.20
-
Cipla 2011 (Spanish version)
Deshpande, Rohit; Sucher, Sandra J.; Winig, LauraCase HBS-517S04Business Ethics and Corporate Social ResponsibilityDr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.Starting at €8.20